Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kapil Bhalla

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
Cancer Research|November 25, 2003
Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cellsRamadevi Nimmanapalli, Purva Bali, Erica O'Bryan, et al.
Nature Cell Biology|October 16, 2007
SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stressYonghua Yang, Wei Fu, Jiandong Chen, et al.
Leukemia Research|September 29, 2007
Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategyIman Jilani, Hagop Kantarjian, Mercedes Gorre, et al.
Molecular Cancer Therapeutics|April 14, 2007
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cellsSangkil Nam, Ann Williams, Adina Vultur, et al.
Cancer Research|October 18, 2002
Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycinRamadevi Nimmanapalli, Erica O'Bryan, Mei Huang, et al.
Molecular Cancer Therapeutics|October 28, 2003
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone BLianne Fuino, Purva Bali, Sylvie Wittmann, et al.
Leukemia Research|December 25, 2007
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activationIman Jilani, Hagop Kantarjian, Homan Faraji, et al.
Cancer Research|April 3, 2004
Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cellsFei Guo, Celia Sigua, Jianguo Tao, et al.
Journal of Family Medicine and Primary Care|October 26, 2020
Association between the socioeconomic determinants and soil-transmitted helminthiasis among school-going children in a rural area of HaryanaRohit Dhaka, Ramesh Verma, Aparna Parmar, et al.
Blood|July 2, 2008
HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cellsRekha Rao, Warren Fiskus, Yonghua Yang, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
Cancer Research|November 25, 2003
Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cellsRamadevi Nimmanapalli, Purva Bali, Erica O'Bryan, et al.
Nature Cell Biology|October 16, 2007
SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stressYonghua Yang, Wei Fu, Jiandong Chen, et al.
Leukemia Research|September 29, 2007
Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategyIman Jilani, Hagop Kantarjian, Mercedes Gorre, et al.
Molecular Cancer Therapeutics|April 14, 2007
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cellsSangkil Nam, Ann Williams, Adina Vultur, et al.
Cancer Research|October 18, 2002
Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycinRamadevi Nimmanapalli, Erica O'Bryan, Mei Huang, et al.
Molecular Cancer Therapeutics|October 28, 2003
Histone deacetylase inhibitor LAQ824 down-regulates Her-2 and sensitizes human breast cancer cells to trastuzumab, taxotere, gemcitabine, and epothilone BLianne Fuino, Purva Bali, Sylvie Wittmann, et al.
Leukemia Research|December 25, 2007
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activationIman Jilani, Hagop Kantarjian, Homan Faraji, et al.
Cancer Research|April 3, 2004
Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cellsFei Guo, Celia Sigua, Jianguo Tao, et al.
Journal of Family Medicine and Primary Care|October 26, 2020
Association between the socioeconomic determinants and soil-transmitted helminthiasis among school-going children in a rural area of HaryanaRohit Dhaka, Ramesh Verma, Aparna Parmar, et al.
Blood|July 2, 2008
HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cellsRekha Rao, Warren Fiskus, Yonghua Yang, et al.
Pageof 16